Search - tctmd.com

Displaying 1 - 20 of 104

Sort: Relevancy | Date

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

L.A. McKeown

March 14, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

L.A. McKeown

June 09, 2023

News Conference News LINC 2023

FDA Approves DETOUR for Percutaneous Bypass in Long, Complex SFA

L.A. McKeown

June 08, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2022

Caitlin E. Cox

April 01, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Features

Bloodlines: How Far Should Cardiologists Go in Treating Family?

Todd Neale

March 10, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

Advertisement

Top Coronary Artery Disease News in 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

FDA Approves Bioresorbable Scaffold for BTK Lesions

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

Top Endovascular News of 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

FDA Approves DETOUR for Percutaneous Bypass in Long, Complex SFA

March 2023 News Roundup

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

SCAAR Registry Delves Into Left Main Revascularization Outcomes

TCTMD’s Top 10 Most Popular Stories for March 2022

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Bloodlines: How Far Should Cardiologists Go in Treating Family?

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content